{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:56:24Z","timestamp":1791910584121,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00467-026-07296-5","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T19:15:38Z","timestamp":1777144538000},"page":"3111-3123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Incidence and risk factors of vancomycin-associated nephrotoxicity among neonates in the intensive care unit: a retrospective cohort study"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4758-200X","authenticated-orcid":false,"given":"Hanouf S.","family":"Bafhaid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0644-338X","authenticated-orcid":false,"given":"Ibraheem H.","family":"Bagbag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Hassan","family":"Dearar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashed S.","family":"Monshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8294-1861","authenticated-orcid":false,"given":"Hanadi H.","family":"Alrammaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6523-6143","authenticated-orcid":false,"given":"Lujain Khalid","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1443-3797","authenticated-orcid":false,"given":"Walaa Anwar","family":"Felemban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5391-1009","authenticated-orcid":false,"given":"Kholod A.","family":"Alhazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5611-3449","authenticated-orcid":false,"given":"Roaa S.","family":"Alharbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"7296_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.100727","volume":"32","author":"P Prusakov","year":"2021","unstructured":"Prusakov P, Goff DA, Wozniak PS et al (2021) A global point prevalence survey of antimicrobial use in neonatal intensive care units: the no-more-antibiotics and resistance (NO-MAS-R) study. EClinicalMedicine 32:100727. https:\/\/doi.org\/10.1016\/j.eclinm.2021.100727","journal-title":"EClinicalMedicine"},{"key":"7296_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.54289\/jcrmh2100101","volume":"1","author":"GM Pacifici","year":"2022","unstructured":"Pacifici GM (2022) Clinical pharmacology of vancomycin in infants and children. J Case Rep Med Hist 1:1\u201313. https:\/\/doi.org\/10.54289\/jcrmh2100101","journal-title":"J Case Rep Med Hist"},{"key":"7296_CR3","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/qco.0000000000000263","volume":"29","author":"JM Lestner","year":"2016","unstructured":"Lestner JM, Hill LF, Heath PT, Sharland M (2016) Vancomycin toxicity in neonates: a review of the evidence. Curr Opin Infect Dis 29:237\u2013247. https:\/\/doi.org\/10.1097\/qco.0000000000000263","journal-title":"Curr Opin Infect Dis"},{"key":"7296_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-023-04085-z","volume":"23","author":"BS Shin","year":"2023","unstructured":"Shin BS, Shin SH, Park SG et al (2023) Factors associated with acute kidney injury among preterm infants administered vancomycin: a retrospective cohort study. BMC Pediatr 23:296. https:\/\/doi.org\/10.1186\/s12887-023-04085-z","journal-title":"BMC Pediatr"},{"key":"7296_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2019.00188","volume":"7","author":"M Tauzin","year":"2019","unstructured":"Tauzin M, Cohen R, Durrmeyer X et al (2019) Continuous-infusion vancomycin in neonates: assessment of a dosing regimen and therapeutic proposal. Front Pediatr 7:188. https:\/\/doi.org\/10.3389\/fped.2019.00188","journal-title":"Front Pediatr"},{"key":"7296_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/antibiotics10040347","volume":"10","author":"M Mej\u00edas-Trueba","year":"2021","unstructured":"Mej\u00edas-Trueba M, Alonso-Moreno M, Herrera-Hidalgo L, Gil-Navarro MV (2021) Target attainment and clinical efficacy for vancomycin in neonates: systematic review. Antibiotics 10:347. https:\/\/doi.org\/10.3390\/antibiotics10040347","journal-title":"Antibiotics"},{"key":"7296_CR7","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/j.2042-7158.1998.tb03342.x","volume":"50","author":"R Silva","year":"1998","unstructured":"Silva R, Reis E, Bispo MA et al (1998) The kinetic profile of vancomycin in neonates. J Pharm Pharmacol 50:1255\u20131260. https:\/\/doi.org\/10.1111\/j.2042-7158.1998.tb03342.x","journal-title":"J Pharm Pharmacol"},{"key":"7296_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3233\/npm-182","volume":"12","author":"E Chung","year":"2019","unstructured":"Chung E, Lee SE, Abraham T et al (2019) Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population. J Neonatal Perinat Med 12:21\u201327. https:\/\/doi.org\/10.3233\/npm-182","journal-title":"J Neonatal Perinat Med"},{"key":"7296_CR9","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1128\/AAC.01968-15","volume":"60","author":"EJH Janssen","year":"2016","unstructured":"Janssen EJH, V\u00e4litalo PAJ, Allegaert K et al (2016) Towards rational dosing algorithms for vancomycin in neonates and infants based on population pharmacokinetic modeling. Antimicrob Agents Chemother 60:1013\u20131021. https:\/\/doi.org\/10.1128\/AAC.01968-15","journal-title":"Antimicrob Agents Chemother"},{"key":"7296_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/bcp.13899","volume":"85","author":"S Leroux","year":"2019","unstructured":"Leroux S, Van Den Anker JN, Smits A et al (2019) Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates. Br J Clin Pharmacol 85:865\u2013867. https:\/\/doi.org\/10.1111\/bcp.13899","journal-title":"Br J Clin Pharmacol"},{"key":"7296_CR11","doi-asserted-by":"publisher","first-page":"831","DOI":"10.6061\/clinics\/2012(07)21","volume":"67","author":"GM Pacifici","year":"2012","unstructured":"Pacifici GM, Allegaert K (2012) Clinical pharmacokinetics of vancomycin in the neonate: a review. Clinics (Sao Paulo) 67:831\u2013837. https:\/\/doi.org\/10.6061\/clinics\/2012(07)21","journal-title":"Clinics (Sao Paulo)"},{"key":"7296_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042052","volume":"23","author":"W-C Kan","year":"2022","unstructured":"Kan W-C, Chen Y-C, Wu V-C, Shiao C-C (2022) Vancomycin-associated acute kidney injury: a narrative review from pathophysiology to clinical application. Int J Mol Sci 23:2052. https:\/\/doi.org\/10.3390\/ijms23042052","journal-title":"Int J Mol Sci"},{"key":"7296_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40272-025-00690-w","volume":"27","author":"Y Gao","year":"2025","unstructured":"Gao Y, Wu T, Pu L et al (2025) Risk factors for nephrotoxicity among neonates receiving vancomycin: a systematic review and meta-analysis. Pediatr Drugs 27:439\u2013448. https:\/\/doi.org\/10.1007\/s40272-025-00690-w","journal-title":"Pediatr Drugs"},{"key":"7296_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12887-017-0777-0","volume":"17","author":"V Bhargava","year":"2017","unstructured":"Bhargava V, Malloy M, Fonseca R (2017) The association between vancomycin trough concentrations and acute kidney injury in the neonatal intensive care unit. BMC Pediatr 17:50. https:\/\/doi.org\/10.1186\/s12887-017-0777-0","journal-title":"BMC Pediatr"},{"key":"7296_CR15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/ejhpharm-2019-002181","volume":"29","author":"TH Dawoud","year":"2022","unstructured":"Dawoud TH, Khan N, Afzal U et al (2022) Assessment of initial vancomycin trough levels and risk factors of vancomycin-induced nephrotoxicity in neonates. Eur J Hosp Pharm 29:44\u201349. https:\/\/doi.org\/10.1136\/ejhpharm-2019-002181","journal-title":"Eur J Hosp Pharm"},{"key":"7296_CR16","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01572-19","volume":"63","author":"M Kalligeros","year":"2019","unstructured":"Kalligeros M, Karageorgos SA, Shehadeh F et al (2019) Systematic review and meta-analysis of the association of acute kidney injury with the concomitant use of vancomycin and piperacillin-tazobactam in children. Antimicrob Agents Chemother 63:e01572-19. https:\/\/doi.org\/10.1128\/AAC.01572-19","journal-title":"Antimicrob Agents Chemother"},{"key":"7296_CR17","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00467-019-04350-3","volume":"35","author":"HJ Murphy","year":"2020","unstructured":"Murphy HJ, Thomas B, Van Wyk B et al (2020) Nephrotoxic medications and acute kidney injury risk factors in the neonatal intensive care unit: clinical challenges for neonatologists and nephrologists. Pediatr Nephrol 35:2077\u20132088. https:\/\/doi.org\/10.1007\/s00467-019-04350-3","journal-title":"Pediatr Nephrol"},{"key":"7296_CR18","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1080\/0886022x.2019.1665546","volume":"41","author":"Y Fan","year":"2019","unstructured":"Fan Y, Ye J, Qian L et al (2019) Risk factors and outcomes of acute kidney injury in ventilated newborns. Ren Fail 41:995\u20131000. https:\/\/doi.org\/10.1080\/0886022x.2019.1665546","journal-title":"Ren Fail"},{"key":"7296_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9256528","volume":"2018","author":"M Al Nuhait","year":"2018","unstructured":"Al Nuhait M, Abu Esba LC, Al Harbi K et al (2018) Acute kidney injury in pediatric treated with vancomycin and piperacillin-tazobactam in tertiary care hospital. Int J Pediatr 2018:9256528. https:\/\/doi.org\/10.1155\/2018\/9256528","journal-title":"Int J Pediatr"},{"key":"7296_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1093171","volume":"11","author":"A Alsultan","year":"2023","unstructured":"Alsultan A, Al Munjem MF, Atiq KM et al (2023) Population pharmacokinetics of vancomycin in very low birth weight neonates. Front Pediatr 11:1093171. https:\/\/doi.org\/10.3389\/fped.2023.1093171","journal-title":"Front Pediatr"},{"key":"7296_CR21","volume-title":"NeoFax (Pediatrics)","author":"Vanderbilt University Medical Center","year":"2022","unstructured":"Vancomycin [monograph]. In: NeoFax (Micromedex) [online database]. Truven Health Analytics (IBM Micromedex): Greenwood Village, CO. Accessed January 05, 2026."},{"key":"7296_CR22","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1542\/peds.2014-3819","volume":"136","author":"DT Selewski","year":"2015","unstructured":"Selewski DT, Charlton JR, Jetton JG et al (2015) Neonatal acute kidney injury. Pediatrics 136:e463\u2013e473. https:\/\/doi.org\/10.1542\/peds.2014-3819","journal-title":"Pediatrics"},{"key":"7296_CR23","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2215\/CJN.15231121","volume":"17","author":"A De Mul","year":"2022","unstructured":"De Mul A, Parvex P, H\u00e9neau A et al (2022) Urine output monitoring for the diagnosis of early-onset acute kidney injury in very preterm infants. Clin J Am Soc Nephrol 17:949\u2013956. https:\/\/doi.org\/10.2215\/CJN.15231121","journal-title":"Clin J Am Soc Nephrol"},{"key":"7296_CR24","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1007\/s00467-024-06287-8","volume":"39","author":"HC Ahn","year":"2024","unstructured":"Ahn HC, Frymoyer A, Boothroyd DB et al (2024) Acute kidney injury in neonates with hypoxic ischemic encephalopathy based on serum creatinine decline compared to KDIGO criteria. Pediatr Nephrol 39:2789\u20132796. https:\/\/doi.org\/10.1007\/s00467-024-06287-8","journal-title":"Pediatr Nephrol"},{"key":"7296_CR25","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1007\/s00467-016-3317-5","volume":"31","author":"C Gupta","year":"2016","unstructured":"Gupta C, Massaro AN, Ray PE (2016) A new approach to define acute kidney injury in term newborns with hypoxic ischemic encephalopathy. Pediatr Nephrol 31:1167\u20131178. https:\/\/doi.org\/10.1007\/s00467-016-3317-5","journal-title":"Pediatr Nephrol"},{"key":"7296_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens10101343","volume":"10","author":"C Minotti","year":"2021","unstructured":"Minotti C, Barbieri E, Giaquinto C, Don\u00e0 D (2021) Vancomycin use in children and neonates across three decades: a bibliometric analysis of the top-cited articles. Pathogens 10:1343. https:\/\/doi.org\/10.3390\/pathogens10101343","journal-title":"Pathogens"},{"key":"7296_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/kisup.2011.32","volume":"Suppl 2","author":"Kidney International Organization","year":"2012","unstructured":"Kidney International Organization (2012) Section 2: AKI Definition. Kidney Int Suppl 2:19\u201336. https:\/\/doi.org\/10.1038\/kisup.2011.32","journal-title":"Kidney Int"},{"key":"7296_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/cc5713","volume":"11","author":"RL Mehta","year":"2007","unstructured":"Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31. https:\/\/doi.org\/10.1186\/cc5713","journal-title":"Crit Care"},{"key":"7296_CR29","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1093\/ckj\/sfs160","volume":"6","author":"JA Lopes","year":"2013","unstructured":"Lopes JA, Jorge S (2013) The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review. Clin Kidney J 6:8\u201314. https:\/\/doi.org\/10.1093\/ckj\/sfs160","journal-title":"Clin Kidney J"},{"key":"7296_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2016.00068","volume":"4","author":"JG Jetton","year":"2016","unstructured":"Jetton JG, Guillet R, Askenazi DJ et al (2016) Assessment of worldwide acute kidney injury epidemiology in neonates: design of a retrospective cohort study. Front Pediatr 4:68. https:\/\/doi.org\/10.3389\/fped.2016.00068","journal-title":"Front Pediatr"},{"key":"7296_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13123446","volume":"13","author":"V Chirico","year":"2024","unstructured":"Chirico V, Lacquaniti A, Tripodi F et al (2024) Acute kidney injury in neonatal intensive care unit: epidemiology, diagnosis and risk factors. J Clin Med 13:3446. https:\/\/doi.org\/10.3390\/jcm13123446","journal-title":"J Clin Med"},{"key":"7296_CR32","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.jsps.2021.04.023","volume":"29","author":"AM Alzahrani","year":"2021","unstructured":"Alzahrani AM, Naeem A, Alwadie AF et al (2021) Causes of vancomycin dosing error; problem detection and practical solutions; a retrospective, single-center, cross-sectional study. Saudi Pharm J 29:616\u2013624. https:\/\/doi.org\/10.1016\/j.jsps.2021.04.023","journal-title":"Saudi Pharm J"},{"key":"7296_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/maj.0000000000000368","volume":"349","author":"S Koppula","year":"2015","unstructured":"Koppula S, Ruben S, Bangash F, Szerlip HM (2015) Pitfalls in dosing vancomycin. Am J Med Sci 349:137\u2013139. https:\/\/doi.org\/10.1097\/maj.0000000000000368","journal-title":"Am J Med Sci"},{"key":"7296_CR34","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP et al (2020) Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureusi nfections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm 77:835\u2013864. https:\/\/doi.org\/10.1093\/ajhp\/zxaa036","journal-title":"Am J Health Syst Pharm"},{"key":"7296_CR35","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1128\/AAC.03620-14","volume":"58","author":"A Frymoyer","year":"2014","unstructured":"Frymoyer A, Hersh AL, El-Komy MH et al (2014) Association between vancomycin trough concentration and area under the concentration-time curve in neonates. Antimicrob Agents Chemother 58:6454\u20136461. https:\/\/doi.org\/10.1128\/AAC.03620-14","journal-title":"Antimicrob Agents Chemother"},{"key":"7296_CR36","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.jpeds.2019.08.046","volume":"215","author":"C Stoops","year":"2019","unstructured":"Stoops C, Stone S, Evans E et al (2019) Baby NINJA (nephrotoxic injury negated by just-in-time action): reduction of nephrotoxic medication-associated acute kidney injury in the neonatal intensive care unit. J Pediatr 215:223-228.e6. https:\/\/doi.org\/10.1016\/j.jpeds.2019.08.046","journal-title":"J Pediatr"},{"key":"7296_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.kint.2016.03.031","volume":"90","author":"SL Goldstein","year":"2016","unstructured":"Goldstein SL, Mottes T, Simpson K et al (2016) A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 90:212\u2013221. https:\/\/doi.org\/10.1016\/j.kint.2016.03.031","journal-title":"Kidney Int"},{"key":"7296_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/npm-210866","volume":"15","author":"Y Al-Jebawi","year":"2022","unstructured":"Al-Jebawi Y, Karalic K, Shekhawat P, Mhanna MJ (2022) The concomitant use of vancomycin and piperacillin-tazobactam is associated with acute kidney injury (AKI) in extremely low birth weight infants (ELBW). J Neonatal Perinatal Med 15:303\u2013309. https:\/\/doi.org\/10.3233\/npm-210866","journal-title":"J Neonatal Perinatal Med"},{"key":"7296_CR39","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1093\/cid\/ciw811","volume":"64","author":"DA Hammond","year":"2017","unstructured":"Hammond DA, Smith MN, Li C et al (2017) Systematic review and metaanalysis of acute kidney injury associated with concomitant vancomycin and piperacillin\/tazobactam. Clin Infect Dis 64:666\u2013674. https:\/\/doi.org\/10.1093\/cid\/ciw811","journal-title":"Clin Infect Dis"},{"key":"7296_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/children10020242","volume":"10","author":"G Lazarovits","year":"2023","unstructured":"Lazarovits G, OfekShlomai N, Kheir R et al (2023) Acute kidney injury in very low birth weight infants: a major morbidity and mortality risk factor. Children 10:242. https:\/\/doi.org\/10.3390\/children10020242","journal-title":"Children"},{"key":"7296_CR41","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s00134-022-06811-0","volume":"48","author":"TA Miano","year":"2022","unstructured":"Miano TA, Hennessy S, Yang W et al (2022) Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study. Intensive Care Med 48:1144\u20131155. https:\/\/doi.org\/10.1007\/s00134-022-06811-0","journal-title":"Intensive Care Med"},{"key":"7296_CR42","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/jcpt.12806","volume":"44","author":"T Zhang","year":"2019","unstructured":"Zhang T, Cheng H, Li Y et al (2019) Paediatric acute kidney injury induced by vancomycin monotherapy versus combined vancomycin and meropenem. J Clin Pharm Ther 44:440\u2013446. https:\/\/doi.org\/10.1111\/jcpt.12806","journal-title":"J Clin Pharm Ther"},{"key":"7296_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10227-0","volume":"25","author":"AM Alshehri","year":"2025","unstructured":"Alshehri AM, Al Yami MS, Aldairem A et al (2025) Evaluating the risk of acute kidney injury and mortality associated with concomitant use of vancomycin with piperacillin\/tazobactam or meropenem in critically ill and non-critically ill patients: a systematic review and meta-analysis. BMC Infect Dis 25:36. https:\/\/doi.org\/10.1186\/s12879-024-10227-0","journal-title":"BMC Infect Dis"},{"key":"7296_CR44","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/jac\/25.4.679","volume":"25","author":"MJ Rybak","year":"1990","unstructured":"Rybak MJ, Albrecht LM, Boike SC, Chandrasekar PH (1990) Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J Antimicrob Chemother 25:679\u2013687. https:\/\/doi.org\/10.1093\/jac\/25.4.679","journal-title":"J Antimicrob Chemother"},{"key":"7296_CR45","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1128\/aac.01568-12","volume":"57","author":"SJ Van Hal","year":"2013","unstructured":"Van Hal SJ, Paterson DL, Lodise TP (2013) Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter. Antimicrob Agents Chemother 57:734\u2013744. https:\/\/doi.org\/10.1128\/aac.01568-12","journal-title":"Antimicrob Agents Chemother"},{"key":"7296_CR46","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00467-018-3966-7","volume":"33","author":"MA Shalaby","year":"2018","unstructured":"Shalaby MA, Sawan ZA, Nawawi E et al (2018) Incidence, risk factors, and outcome of neonatal acute kidney injury: a prospective cohort study. Pediatr Nephrol 33:1617\u20131624. https:\/\/doi.org\/10.1007\/s00467-018-3966-7","journal-title":"Pediatr Nephrol"},{"key":"7296_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s00467-021-05251-0","volume":"37","author":"Y Wu","year":"2022","unstructured":"Wu Y, Wang H, Pei J et al (2022) Acute kidney injury in premature and low birth weight neonates: a systematic review and meta-analysis. Pediatr Nephrol 37:275\u2013287. https:\/\/doi.org\/10.1007\/s00467-021-05251-0","journal-title":"Pediatr Nephrol"},{"key":"7296_CR48","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2018.0322","volume":"172","author":"MW Harer","year":"2018","unstructured":"Harer MW, Askenazi DJ, Boohaker LJ et al (2018) Association between early caffeine citrate administration and risk of acute kidney injury in preterm neonates: results from the AWAKEN study. JAMA Pediatr 172:e180322. https:\/\/doi.org\/10.1001\/jamapediatrics.2018.0322","journal-title":"JAMA Pediatr"},{"key":"7296_CR49","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jpeds.2016.01.051","volume":"172","author":"JB Carmody","year":"2016","unstructured":"Carmody JB, Harer MW, Denotti AR et al (2016) Caffeine exposure and risk of acute kidney injury in a retrospective cohort of very low birth weight neonates. J Pediatr 172:63-68.e1. https:\/\/doi.org\/10.1016\/j.jpeds.2016.01.051","journal-title":"J Pediatr"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07296-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-026-07296-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-026-07296-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:06:22Z","timestamp":1785452782000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-026-07296-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":49,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["7296"],"URL":"https:\/\/doi.org\/10.1007\/s00467-026-07296-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research Ethics Committee at the Directorate of Health Affairs in Makkah Region (H-02-K-076\u20131222-866), and the requirement to obtain informed consent was waived.","order":1,"name":"Ethics","label":"Ethical approval and informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}